Cue Biopharma, Inc.
CUE· Nasdaq
Released May 8, 2019, after the close
10-Q filed May 8, 2019, 38 days after period end · 0001564590-19-017298
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|
| Revenue | $370.00K | — | — |
| Net Income | -$11.27M | -$7.52M | -$3.35M |
| EPS Diluted | -$0.54 | -$0.37 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cue Biopharma, Inc. · CIK 1645460 · Engraved from SEC EDGAR